John Lanzafame

John Lanzafame (Director) was the first President of MyoCardioCare, Inc., having served in that role from the company’s formation in 2009 through 2014 and immediately prior served as CEO of Biophan Technologies, Inc., a public medical technology development company from which MyoCardioCare acquired the technology and intellectual property used in the development of its medical device for the treatment of cardiac arrest. Lanzafame currently is the Director of Commercial and Laboratory Operations for iuvo BioScience, a private Rochester, NY-based organization focused on testing services for the medical device and pharmaceutical industries. He brings over twenty-five years of experience in the medical device sector in both public and private organizations. He has extensive experience in business development, sales, marketing and executive-level management with a strong technical background in product development and commercialization.

John has negotiated dozens of strategic partnerships and technology licenses between diverse entities ranging from startups to Fortune 50 companies to leading government research laboratories and universities. He has also led product development activities for Class 3 to Class 1 medical devices and pharmaceutical formulations for novel oncology treatments. Lanzafame has also filled a variety of other roles in both public and private companies, including CEO of Isoflux Incorporated, a private technology company serving the medical device and optics industries, and President of STS Biopolymers, Inc., a private OEM company that developed high-performance polymer coatings for the medical device industry, including lubricious coatings for catheters and guidewires and drug-eluting coatings for stents and central catheters. He has also served on the board of directors of several private and public companies. John holds a bachelor’s degree in chemical engineering from the University of Dayton and a master’s degree in industrial engineering management from Rochester Institute of Technology.